“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Verve Therapeutics
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verves gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a Best Places to Work by the Boston Globe. Verve is headquartered in Boston, Massachusetts
| C-Level 6 | VP - Level14 |
| Director70 | Manager24 |
| Others140 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| Pain Points | Locations | Technologies |
|---|---|---|
| Big Data | Boston, MA | spark, communication, continuous improvement, testing, staffing, collaboration, troubleshooting, share, operations, infrastructure, talent acquisition, gmp |
| Build & Release | Boston, MA | continuous improvement, testing, staffing, cgmp, integrity, security, continuous improvements, spark, communication, compliance, usability, share, data governance, troubleshooting, operations, protection, infrastructure, gmp, privacy, e, risk, collaboration, sox, talent acquisition |
| Compliance | Boston, MA | continuous improvement, testing, staffing, cgmp, integrity, security, continuous improvements, quality assurance, spark, communication, audit, data analysis, compliance, usability, share, data governance, r, troubleshooting, operations, protection, financial, gmp, infrastructure, privacy, e, sas, risk, data management, collaboration, data collection, sox, ec, talent acquisition |
| Digital Transformation | Boston, MA | continuous improvement, testing, staffing, cgmp, integrity, security, continuous improvements, quality assurance, spark, communication, audit, data analysis, compliance, usability, share, data governance, r, troubleshooting, operations, protection, financial, gmp, infrastructure, privacy, e, sas, risk, data management, collaboration, data collection, sox, ec, talent acquisition |
| Embedded Design | Boston, MA | continuous improvement, testing, staffing, integrity, security, continuous improvements, spark, communication, audit, data analysis, compliance, usability, share, data governance, r, troubleshooting, operations, protection, infrastructure, gmp, privacy, e, sas, data management, collaboration, data collection, sox, talent acquisition |
Verve Therapeutics looking to hire in Build & Release in Boston, MA
Verve Therapeutics looking to hire in BI in Boston, MA
Verve Therapeutics looking to hire in Animation in Boston, MA
Amazon connect
Collaborator
Gcp
Siem
Access
Access management
Accessibility
Analytics
Archiving
Assessment
The CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe CompanyVerve is a clinical-stage genetic medicines company established with a mission to solv...
View MoreThe independent journey of Verve Therapeutics on public markets concluded on July 25, 2025, when the biotechnology firm was officially delisted from the
Read MoreEli Lilly's Strategic Acquisition of Verve Therapeutics: Pioneering Gene Editing in Cardiometabolic Disease and Unlocking Long-Term Shareholder Value.
Read MoreEli Lilly and Company (LLY) has finalized its acquisition of Verve Therapeutics, a clinical-stage firm located in Boston. Verve Therapeutics focuses on the
Read MoreINDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve
Read MoreVerve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verves gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023,...
Verve therapeutics operates in the Biotechnology research industry.
Verve therapeutics's revenue is $32.33m
Verve therapeutics has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.